Lamivudine inhibits hepatitis B virus replication in kidney graft recipients

被引：22

作者：

Goffin, E

Horsmans, Y

Cornu, C

Squifflet, JP

Pirson, Y

机构：

[1] Hop St Luc, Louvain Med Sch, Dept Nephrol, B-1200 Brussels, Belgium

[2] Hop St Luc, Louvain Med Sch, Dept Hepatol, B-1200 Brussels, Belgium

[3] Hop St Luc, Louvain Med Sch, Dept Virol, B-1200 Brussels, Belgium

[4] Hop St Luc, Louvain Med Sch, Dept Renal Transplantat, B-1200 Brussels, Belgium

来源：

TRANSPLANTATION | 1998年 / 66卷 / 03期

关键词：

D O I：

10.1097/00007890-199808150-00025

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：407 / 409

页数：3

共 11 条

[1] Efficacy of lamivudine in chronic hepatitis B patients with active viral replication and decompensated cirrhosis undergoing liver transplantation [J].

Bain, VG ;

Kneteman, NM ;

Ma, MM ;

Gutfreund, K ;

Shapiro, JA ;

Fischer, K ;

Tipples, G ;

Lee, H ;

Jewell, LD ;

Tyrrell, DL .

TRANSPLANTATION, 1996, 62 (10) :1456-1462

[2] EFFICACY OF LAMIVUDINE ON REPLICATION OF HEPATITIS-B VIRUS IN HIV-INFECTED PATIENTS [J].

BENHAMOU, Y ;

DOHIN, E ;

LUNELFABIANI, F ;

POYNARD, T ;

HURAUX, JM ;

KATLAMA, C ;

OPOLON, P ;

GENTILINI, M .

LANCET, 1995, 345 (8946) :396-397

[3] A PRELIMINARY TRIAL OF LAMIVUDINE FOR CHRONIC HEPATITIS-B INFECTION [J].

DIENSTAG, JL ;

PERRILLO, RP ;

SCHIFF, ER ;

BARTHOLOMEW, M ;

VICARY, C ;

RUBIN, M .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (25) :1657-1661

[4] THE INCREASED RISK OF FATAL LIVER-DISEASE IN RENAL-TRANSPLANT PATIENTS WHO ARE HEPATITIS-BE ANTIGEN AND OR HBV DNA POSITIVE [J].

FAIRLEY, CK ;

MIJCH, A ;

GUST, ID ;

NICHILSON, S ;

DIMITRAKAKIS, M ;

LUCAS, CR .

TRANSPLANTATION, 1991, 52 (03) :497-500

[5] Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis [J].

Grellier, L ;

Mutimer, D ;

Ahmed, M ;

Brown, D ;

Burroughs, AK ;

Rolles, K ;

McMaster, P ;

Beranek, P ;

Kennedy, F ;

Kibbler, H ;

McPhillips, P ;

Elias, E ;

Dusheiko, G .

LANCET, 1996, 348 (9036) :1212-1215

[6] Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine [J].

Ling, R ;

Mutimer, D ;

Ahmed, N ;

Boxall, EH ;

Elias, E ;

Dusheiko, GM ;

Harrison, TJ .

HEPATOLOGY, 1996, 24 (03) :711-713

[7] INTERFERON-ALPHA-INDUCED ACUTE RENAL-ALLOGRAFT REJECTION [J].

MAGNONE, M ;

HOLLEY, JL ;

SHAPIRO, R ;

SCANTLEBURY, V ;

MCCAULEY, J ;

JORDAN, M ;

VIVAS, C ;

STARZL, T ;

JOHNSON, JP .

TRANSPLANTATION, 1995, 59 (07) :1068-1070

[8] Acute renal failure in kidney transplant patients treated with interferon alpha 2b for chronic hepatitis C [J].

Rostaing, L ;

Modesto, A ;

Baron, E ;

Cisterne, JM ;

Chabannier, MH ;

Durand, D .

NEPHRON, 1996, 74 (03) :512-516

[9] Efficacy and safety of lamivudine on replication of recurrent hepatitis B after cadaveric renal transplantation [J].

Rostaing, L ;

Henry, S ;

Cisterne, JM ;

Duffaut, M ;

Icart, J ;

Durand, D .

TRANSPLANTATION, 1997, 64 (11) :1624-1627

[10] Clinical implications of lamivudine resistance by HBV [J].

Schalm, SW .

LANCET, 1997, 349 (9044) :3-4

← 1 2 →